Nephrol Dial Transplant (2003) 18: 1731-1740
© 2003 European Renal Association-European Dialysis and Transplant Association
Rapid Communication
Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality
Service d’Hémodialyse, Hôpital F.H. Manhès, Fleury-Mérogis, France
Correspondence and offprint requests to: Dr Gérard M. London, Hôpital F.H. Manhès, 8 Grande Rue, F-91712 Fleury-Mérogis Cédex, France. Email: glondon{at}club-internet.fr
Abstract
Background. Cross-sectional and follow-up studies on end-stage renal disease patients showed that arterial calcifications are associated with cardiovascular (CV) morbidity and are an independent predictor of all-cause and CV mortality. However, these studies did not examine the impact on prognosis according to the type of calcification, i.e. intimal vs medial. Arterial media calcification (AMC), a non-occlusive condition, affects haemodynamics differently from arterial intima calcification (AIC), which occurs in atherosclerotic plaques. The aim of this study was to investigate the prognostic value of AMC in relationship to all-cause or CV mortality for stable haemodialysis (HD) patients.
Methods. We included 202 such patients in the present study. At baseline, soft-tissue native radiograms of the pelvis and the thigh were analysed for the presence and type (AMC vs AIC) of arterial calcifications. All patients underwent B-mode ultrasonography of the common carotid artery to determine the presence of atherosclerotic calcified plaques, measurement of aortic pulse wave velocity and echocardiography.
Results. AIC was usually observed in older patients with a clinical history of atherosclerosis before starting HD treatment and typical risk factors associated with atherosclerotic disease. AMC was observed in young and middle-aged patients without conventional atherosclerotic risk factors. AMC was closely associated with the duration of HD and calcium–phosphate disorders, including the oral dose of elemental calcium prescribed as phosphate binder (CaCO3). Compared to patients with AIC, patients with AMC had a longer survival, but in turn their survival was significantly shorter than that of patients without calcifications.
Conclusions. AMC is a strong prognostic marker of all-cause and CV mortality in HD patients, independently of classical atherogenic factors. The principal effect of AMC on arterial function is increased arterial stiffness.
Keywords: arterial calcifications; haemodialysis; mortality
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. L. Demer and Y. Tintut Vascular Calcification: Pathobiology of a Multifaceted Disease Circulation, June 3, 2008; 117(22): 2938 - 2948. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mathew, K. S. Tustison, T. Sugatani, L. R. Chaudhary, L. Rifas, and K. A. Hruska The Mechanism of Phosphorus as a Cardiovascular Risk Factor in CKD J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1092 - 1105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Speer, B. Cs. Fekete, T. E. H. Othmane, T. Szabo, J. Egresits, E. Fodor, I. Kiss, A. G. Logan, J. Nemcsik, A. Szabo, et al. Serum osteoprotegerin level, carotid-femoral pulse wave velocity and cardiovascular survival in haemodialysis patients Nephrol. Dial. Transplant., May 13, 2008; (2008) gfn242v2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Raggi and M. Kleerekoper Contribution of Bone and Mineral Abnormalities to Cardiovascular Disease in Patients with Chronic Kidney Disease Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 836 - 843. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Schlieper, M. Hristov, V. Brandenburg, T. Kruger, R. Westenfeld, A. H. Mahnken, E. Yagmur, G. Boecker, N. Heussen, U. Gladziwa, et al. Predictors of low circulating endothelial progenitor cell numbers in haemodialysis patients Nephrol. Dial. Transplant., March 19, 2008; (2008) gfn103v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Towler Vascular Calcification: A Perspective On An Imminent Disease Epidemic IBMS BoneKEy, February 1, 2008; 5(2): 41 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. D. Toussaint, K. K. Lau, B. J. Strauss, K. R. Polkinghorne, and P. G. Kerr Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease Nephrol. Dial. Transplant., February 1, 2008; 23(2): 586 - 593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Moe and N. X. Chen Mechanisms of Vascular Calcification in Chronic Kidney Disease J. Am. Soc. Nephrol., February 1, 2008; 19(2): 213 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ferreira, J. M. Frazao, M.-C. Monier-Faugere, C. Gil, J. Galvao, C. Oliveira, J. Baldaia, I. Rodrigues, C. Santos, S. Ribeiro, et al. Effects of Sevelamer Hydrochloride and Calcium Carbonate on Renal Osteodystrophy in Hemodialysis Patients J. Am. Soc. Nephrol., February 1, 2008; 19(2): 405 - 412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Gnudi Serum intact parathyroid hormone in diabetic patients on haemodialysis: what is the treatment goal? Nephrol. Dial. Transplant., January 1, 2008; 23(1): 24 - 26. [Full Text] [PDF]
|
|
|
|
|
|
P. Messa, F. Macario, M. Yaqoob, K. Bouman, J. Braun, B. von Albertini, H. Brink, F. Maduell, H. Graf, J. M. Frazao, et al. The OPTIMA Study: Assessing a New Cinacalcet (Sensipar/Mimpara) Treatment Algorithm for Secondary Hyperparathyroidism Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 36 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Caglar, M. I. Yilmaz, M. Saglam, E. Cakir, C. Acikel, T. Eyileten, M. Yenicesu, Y. Oguz, A. Vural, J. J. Carrero, et al. Short-Term Treatment with Sevelamer Increases Serum Fetuin-A Concentration and Improves Endothelial Dysfunction in Chronic Kidney Disease Stage 4 Patients Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 61 - 68. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Kovesdy, R. Mehrotra, and K. Kalantar-Zadeh Battleground: Chronic Kidney Disorders Mineral and Bone Disease Calcium Obsession, Vitamin D, and Binder Confusion Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 168 - 173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Andress Bone and Mineral Guidelines for Patients with Chronic Kidney Disease: A Call for Revision Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 179 - 183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Bushinsky and P. Messa Efficacy of Early Treatment with Calcimimetics in Combination with Reduced Doses of Vitamin D Sterols in Dialysis Patients NDT Plus, January 1, 2008; 1(suppl_1): i18 - i23. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Sigrist, M. W. Taal, P. Bungay, and C. W. McIntyre Progressive Vascular Calcification over 2 Years Is Associated with Arterial Stiffening and Increased Mortality in Patients with Stages 4 and 5 Chronic Kidney Disease Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1241 - 1248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Chonchol, V. Aboyans, P. Lacroix, G. Smits, T. Berl, and M. Laskar Long-term outcomes after coronary artery bypass grafting: Preoperative kidney function is prognostic J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 683 - 689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yamada, S. Fujimoto, R. Nishiura, H. Komatsu, M. Tatsumoto, Y. Sato, S. Hara, S. Hisanaga, H. Ochiai, H. Nakao, et al. Risk factors of the progression of abdominal aortic calcification in patients on chronic haemodialysis Nephrol. Dial. Transplant., July 1, 2007; 22(7): 2032 - 2037. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Nogueira and M. Weir The Unique Character of Cardiovascular Disease in Chronic Kidney Disease and Its Implications for Treatment with Lipid-Lowering Drugs Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 766 - 785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Stubbs, S. Liu, W. Tang, J. Zhou, Y. Wang, X. Yao, and L. D. Quarles Role of Hyperphosphatemia and 1,25-Dihydroxyvitamin D in Vascular Calcification and Mortality in Fibroblastic Growth Factor 23 Null Mice J. Am. Soc. Nephrol., July 1, 2007; 18(7): 2116 - 2124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Sabit, C. E. Bolton, P. H. Edwards, R. J. Pettit, W. D. Evans, C. M. McEniery, I. B. Wilkinson, J. R. Cockcroft, and D. J. Shale Arterial Stiffness and Osteoporosis in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1259 - 1265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Krasniak, M. Drozdz, M. Pasowicz, G. Chmiel, M. Michalek, D. Szumilak, P. Podolec, P. Klimeczek, M. Konieczynska, E. Wicher-Muniak, et al. Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients Nephrol. Dial. Transplant., February 1, 2007; 22(2): 515 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. D. Toussaint, K. K. Lau, K. R. Polkinghorne, and P. G. Kerr Measurement of vascular calcification using CT fistulograms Nephrol. Dial. Transplant., February 1, 2007; 22(2): 484 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mathew, R. J. Lund, F. Strebeck, K. S. Tustison, T. Geurs, and K. A. Hruska Reversal of the Adynamic Bone Disorder and Decreased Vascular Calcification in Chronic Kidney Disease by Sevelamer Carbonate Therapy J. Am. Soc. Nephrol., January 1, 2007; 18(1): 122 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Nikolov, N. Joki, T. Drueke, and Z. Massy Beyond phosphate--role of uraemic toxins in cardiovascular calcification Nephrol. Dial. Transplant., December 1, 2006; 21(12): 3354 - 3357. [Full Text] [PDF]
|
|
|
|
|
|
A. L.M. de Francisco, C. Pinera, R. Palomar, and M. Arias Impact of Treatment with Calcimimetics on Hyperparathyroidism and Vascular Mineralization J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S281 - S285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Johnson, J. A. Leopold, and J. Loscalzo Vascular Calcification: Pathobiological Mechanisms and Clinical Implications Circ. Res., November 10, 2006; 99(10): 1044 - 1059. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Galassi, D. M. Spiegel, A. Bellasi, G. A. Block, and P. Raggi Accelerated vascular calcification and relative hypoparathyroidism in incident haemodialysis diabetic patients receiving calcium binders Nephrol. Dial. Transplant., November 1, 2006; 21(11): 3215 - 3222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Persy, A. Postnov, E. Neven, G. Dams, M. De Broe, P. D'Haese, and N. De Clerck High-Resolution X-Ray Microtomography Is a Sensitive Method to Detect Vascular Calcification in Living Rats With Chronic Renal Failure Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 2110 - 2116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Wheeler, J. Floege, and N. Lameire NDT contributes to a collection of 100 seminal papers published by Oxford University Press. Nephrol. Dial. Transplant., August 1, 2006; 21(8): 2047 - 2048. [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Wu-Wong, W. Noonan, J. Ma, D. Dixon, M. Nakane, A. L. Bolin, K. A. Koch, S. Postl, S. J. Morgan, and G. A. Reinhart Role of Phosphorus and Vitamin D Analogs in the Pathogenesis of Vascular Calcification J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 90 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Moe and G. M. Chertow The Case against Calcium-Based Phosphate Binders Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 697 - 703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Schwarz, B. K. Trivedi, K. Kalantar-Zadeh, and C. P. Kovesdy Association of Disorders in Mineral Metabolism with Progression of Chronic Kidney Disease Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 825 - 831. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Qin, M. A. Corriere, L. M. Matrisian, and R. J. Guzman Matrix Metalloproteinase Inhibition Attenuates Aortic Calcification Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1510 - 1516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Arenas, F. Alvarez-Ude, M. T. Gil, A. Soriano, J. J. Egea, I. Millan, M. L. Amoedo, S. Muray, and M. A. Carreton Application of NKF-K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1663 - 1668. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ketteler, G. Schlieper, and J. Floege Calcification and Cardiovascular Health: New Insights Into an Old Phenomenon Hypertension, June 1, 2006; 47(6): 1027 - 1034. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Silvestro, N. Diehm, H. Savolainen, D.-D. Do, J. Vogele, F. Mahler, S. Zwicky, and I. Baumgartner Falsely high ankle-brachial index predicts major amputation in critical limb ischemia Vascular Medicine, May 1, 2006; 11(2): 69 - 74. [Abstract] [PDF]
|
|
|
|
|
|
C. M. Shanahan Vascular calcification--a matter of damage limitation? Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1166 - 1169. [Full Text] [PDF]
|
|
|
|
|
|
X. Li, H.-Y. Yang, and C. M. Giachelli Role of the Sodium-Dependent Phosphate Cotransporter, Pit-1, in Vascular Smooth Muscle Cell Calcification Circ. Res., April 14, 2006; 98(7): 905 - 912. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. TOWLER, J.-S. SHAO, S.-L. CHENG, J. M. PINGSTERHAUS, and A. P. LOEWY Osteogenic Regulation of Vascular Calcification Ann. N.Y. Acad. Sci., April 1, 2006; 1068(1): 327 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Pauletto and M. Rattazzi Inflammation and hypertension: the search for a link Nephrol. Dial. Transplant., April 1, 2006; 21(4): 850 - 853. [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang, W. Zhang, Y. Zhang, Y. Yang, L. Sun, S. Hu, J. Chen, C. Zhang, Y. Zheng, Y. Zhen, et al. VKORC1 Haplotypes Are Associated With Arterial Vascular Diseases (Stroke, Coronary Heart Disease, and Aortic Dissection) Circulation, March 28, 2006; 113(12): 1615 - 1621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sigrist, P. Bungay, M. W. Taal, and C. W. McIntyre Vascular calcification and cardiovascular function in chronic kidney disease Nephrol. Dial. Transplant., March 1, 2006; 21(3): 707 - 714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Williams Coronary Revascularization in Diabetic Chronic Kidney Disease/End-Stage Renal Disease: A Nephrologist's Perspective Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 209 - 220. [Full Text] [PDF]
|
|
|
|
|
|
C. W. McIntyre Is it practical to screen dialysis patients for vascular calcification? Nephrol. Dial. Transplant., February 1, 2006; 21(2): 251 - 254. [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Schrier Role of Diminished Renal Function in Cardiovascular Mortality: Marker or Pathogenetic Factor? J. Am. Coll. Cardiol., January 3, 2006; 47(1): 1 - 8. [Abstract] [Full Text]
|
|
|
|
|
|
P. Houillier, M. Froissart, G. Maruani, and A. Blanchard What serum calcium can tell us and what it can't Nephrol. Dial. Transplant., January 1, 2006; 21(1): 29 - 32. [Full Text] [PDF]
|
|
|
|
|
|
M. Morena, N. Terrier, I. Jaussent, H. Leray-Moragues, L. Chalabi, J.-P. Rivory, F. Maurice, C. Delcourt, J.-P. Cristol, B. Canaud, et al. Plasma Osteoprotegerin Is Associated with Mortality in Hemodialysis Patients J. Am. Soc. Nephrol., January 1, 2006; 17(1): 262 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A. Khan, I. Ma, C. R. Thompson, K. Humphries, D. N. Salem, M. J. Sarnak, and A. Levin Kidney Function and Mortality among Patients with Left Ventricular Systolic Dysfunction J. Am. Soc. Nephrol., January 1, 2006; 17(1): 244 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W. Merx, C. Schafer, R. Westenfeld, V. Brandenburg, S. Hidajat, C. Weber, M. Ketteler, and W. Jahnen-Dechent Myocardial Stiffness, Cardiac Remodeling, and Diastolic Dysfunction in Calcification-Prone Fetuin-A-Deficient Mice J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3357 - 3364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Y. Qunibi Reducing the Burden of Cardiovascular Calcification in Patients with Chronic Kidney Disease J. Am. Soc. Nephrol., November 1, 2005; 16(11_suppl_2): S95 - S102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Nolan Strategies for Improving Long-Term Survival in Patients with ESRD J. Am. Soc. Nephrol., November 1, 2005; 16(11_suppl_2): S120 - S127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Zakeri, N. Freemantle, V. Barnett, G. W. Lipkin, R. S. Bonser, T. R. Graham, S. J. Rooney, I. C. Wilson, R. Cramb, B. E. Keogh, et al. Relation Between Mild Renal Dysfunction and Outcomes After Coronary Artery Bypass Grafting Circulation, August 30, 2005; 112(9_suppl): I-270 - I-275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Sigrist, L. Devlin, M. W. Taal, R. J. Fluck, and C. W. McIntyre Length of interdialytic interval influences serum calcium and phosphorus concentrations Nephrol. Dial. Transplant., August 1, 2005; 20(8): 1643 - 1646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Y.-M. Wang, J. Woo, C. W.-K. Lam, M. Wang, I. H.-S. Chan, P. Gao, S.-F. Lui, P. K.-T. Li, and J. E. Sanderson Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients Nephrol. Dial. Transplant., August 1, 2005; 20(8): 1676 - 1685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-G. Asmus, J. Braun, R. Krause, R. Brunkhorst, H. Holzer, W. Schulz, H.-H. Neumayer, P. Raggi, and J. Bommer Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density Nephrol. Dial. Transplant., August 1, 2005; 20(8): 1653 - 1661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Higgins, S. A. Marvel, and J. D. Morrisett Quantification of Calcification in Atherosclerotic Lesions Arterioscler. Thromb. Vasc. Biol., August 1, 2005; 25(8): 1567 - 1576. [Abstract] [Full Text] [PDF]
|
|